FIELD: medicine, gynecology, pharmacy.
SUBSTANCE: invention relates to a method for supporting amenorrhea in women subjecting the constant progestin therapy providing to induce endometrial atrophy and to avoid significant unfavorable adverse effects that accompanying administration of progesin usually. Invention provides the complete amenorrhea without intermittent bleeding or secretion of small blood amount from vagina and without significant unfavorable adverse effects as can be occur in other methods. The curative effect is attained due to the constant intravaginal administration of progestin in water-insoluble, water-swelling cross-linked polymer based on polycarboxylic acid.
EFFECT: improved supporting method, valuable medicinal properties of composition.
7 cl, 3 dwg, 2 ex
Authors
Dates
2005-09-27—Published
1998-10-21—Filed